(Q45174694)

10 December 2017

C-reactive protein: history and revival (English)

1 reference

10 December 2017

Hans Ablij

1

1 reference

PubMed ID

12384129

10 December 2017

Arend Meinders

series ordinal

2

1 reference

10 December 2017

1 October 2002

1 reference

European Journal of Internal Medicine

10 December 2017

1 reference

10 December 2017

13

1 reference

10 December 2017

412

1 reference

10 December 2017

7

1 reference

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Historical perspective on C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Human C-reactive protein: expression, structure, and function

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

The physiological structure of human C-reactive protein and its complex with phosphocholine

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Generation of C-reactive protein and complement components in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Expression of C-reactive protein in the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Structure and function of the pentraxins

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Topology and structure of the C1q-binding site on C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-reactive protein in acute viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Clinical applications of C-reactive protein in pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

The value of C-reactive protein measurement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-reactive protein in ischemic stroke: an independent prognostic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

The effect of aspirin on C-reactive protein as a marker of risk in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Detection of Chlamydia pneumoniae in arterial tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Oxidants and antioxidants in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900132-2

7 January 2021

10.1016/S0953-6205(02)00132-2

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

12384129